• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨损伤合成中的蛋白质-蛋白质相互作用。

Protein-Protein Interactions in Translesion Synthesis.

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Rd, Storrs, CT 06029-3092, USA.

出版信息

Molecules. 2021 Sep 13;26(18):5544. doi: 10.3390/molecules26185544.

DOI:10.3390/molecules26185544
PMID:34577015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8468184/
Abstract

Translesion synthesis (TLS) is an error-prone DNA damage tolerance mechanism used by actively replicating cells to copy past DNA lesions and extend the primer strand. TLS ensures that cells continue replication in the presence of damaged DNA bases, albeit at the expense of an increased mutation rate. Recent studies have demonstrated a clear role for TLS in rescuing cancer cells treated with first-line genotoxic agents by allowing them to replicate and survive in the presence of chemotherapy-induced DNA lesions. The importance of TLS in both the initial response to chemotherapy and the long-term development of acquired resistance has allowed it to emerge as an interesting target for small molecule drug discovery. Proper TLS function is a complicated process involving a heteroprotein complex that mediates multiple attachment and switching steps through several protein-protein interactions (PPIs). In this review, we briefly describe the importance of TLS in cancer and provide an in-depth analysis of key TLS PPIs, focusing on key structural features at the PPI interface while also exploring the potential druggability of each key PPI.

摘要

跨损伤合成(TLS)是一种易错的 DNA 损伤容忍机制,活跃复制的细胞利用该机制复制 DNA 损伤并延伸引物链。TLS 确保细胞在存在受损 DNA 碱基的情况下继续复制,尽管这会增加突变率。最近的研究表明,TLS 在挽救接受一线致基因突变药物治疗的癌细胞方面发挥了明确作用,使它们能够在化疗诱导的 DNA 损伤存在的情况下复制和存活。TLS 在化疗初始反应和获得性耐药的长期发展中的重要性使其成为小分子药物发现的一个有趣靶点。正确的 TLS 功能是一个复杂的过程,涉及一个异源蛋白复合物,该复合物通过几个蛋白-蛋白相互作用(PPIs)介导多个附着和切换步骤。在这篇综述中,我们简要描述了 TLS 在癌症中的重要性,并对关键的 TLS PPI 进行了深入分析,重点关注 PPI 界面上的关键结构特征,同时还探讨了每个关键 PPI 的潜在成药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/b462bb8f2cef/molecules-26-05544-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/6b5ebbe4acbe/molecules-26-05544-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/4717cefac3e4/molecules-26-05544-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/a01a9c820cec/molecules-26-05544-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/af7afda2d1b9/molecules-26-05544-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/e19d9cd66e02/molecules-26-05544-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/41eed4335c38/molecules-26-05544-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/b9acdf28026a/molecules-26-05544-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/e165a8145376/molecules-26-05544-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/b462bb8f2cef/molecules-26-05544-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/6b5ebbe4acbe/molecules-26-05544-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/4717cefac3e4/molecules-26-05544-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/a01a9c820cec/molecules-26-05544-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/af7afda2d1b9/molecules-26-05544-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/e19d9cd66e02/molecules-26-05544-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/41eed4335c38/molecules-26-05544-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/b9acdf28026a/molecules-26-05544-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/e165a8145376/molecules-26-05544-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24c/8468184/b462bb8f2cef/molecules-26-05544-g009.jpg

相似文献

1
Protein-Protein Interactions in Translesion Synthesis.跨损伤合成中的蛋白质-蛋白质相互作用。
Molecules. 2021 Sep 13;26(18):5544. doi: 10.3390/molecules26185544.
2
Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1.结构方法鉴定靶向跨损伤合成聚合酶 Rev1 的先导支架。
J Chem Inf Model. 2018 Nov 26;58(11):2266-2277. doi: 10.1021/acs.jcim.8b00535. Epub 2018 Oct 19.
3
Translesion synthesis inhibitors as a new class of cancer chemotherapeutics.跨损伤合成抑制剂作为一类新型的癌症化疗药物。
Expert Opin Investig Drugs. 2021 Jan;30(1):13-24. doi: 10.1080/13543784.2021.1850692. Epub 2020 Dec 3.
4
Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.靶向Rev1-CT/RIR蛋白-蛋白相互作用的小分子跨损伤合成抑制剂的鉴定
ACS Chem Biol. 2017 Jul 21;12(7):1903-1912. doi: 10.1021/acschembio.6b01144. Epub 2017 Jun 9.
5
Filling gaps in translesion DNA synthesis in human cells.填补人类细胞中跨损伤DNA合成的缺口。
Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt B):127-142. doi: 10.1016/j.mrgentox.2018.02.004. Epub 2018 Feb 23.
6
Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction.先导化合物分析鉴定用于逆转录酶 REV1-CT/RIR 跨损伤合成蛋白-蛋白相互作用的小分子抑制剂。
Bioorg Med Chem. 2024 May 15;106:117755. doi: 10.1016/j.bmc.2024.117755. Epub 2024 May 9.
7
[Structural Basis of the Multifunctional Hub Protein and Identification of a Small-molecule Compound for Drug Discovery].[多功能枢纽蛋白的结构基础及用于药物研发的小分子化合物的鉴定]
Yakugaku Zasshi. 2019;139(7):969-973. doi: 10.1248/yakushi.19-00092.
8
The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.Rev1-聚合酶ζ跨损伤合成突变体:结构、相互作用及抑制作用
Enzymes. 2019;45:139-181. doi: 10.1016/bs.enz.2019.07.001. Epub 2019 Aug 9.
9
Polymerase Delta in Eukaryotes: How is It Transiently Exchanged with Specialized DNA Polymerases During Translesion DNA Synthesis?真核生物中的聚合酶δ:在跨损伤DNA合成过程中,它是如何与特殊DNA聚合酶进行瞬时交换的?
Curr Protein Pept Sci. 2018;19(8):790-804. doi: 10.2174/1389203719666180430155625.
10
Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.破坏 MAD2L2-Rev1 复合物可增强 DNA 损伤时的细胞死亡。
Molecules. 2022 Jan 19;27(3):636. doi: 10.3390/molecules27030636.

引用本文的文献

1
Human TLS DNA polymerase: saviors or threats under replication stress?人类跨损伤合成DNA聚合酶:复制应激下的救星还是威胁?
Mol Cell Biochem. 2025 May 23. doi: 10.1007/s11010-025-05291-2.
2
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review).睾丸生殖细胞肿瘤中顺铂敏感性和耐药性的机制及潜在治疗药物(综述)
Exp Ther Med. 2025 Feb 24;29(4):82. doi: 10.3892/etm.2025.12832. eCollection 2025 Apr.
3
Molecular mechanisms of DNA lesion and repair during antibody somatic hypermutation.

本文引用的文献

1
Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability.靶向跨损伤合成(TLS)以暴露复制间隙,这是一种独特的癌症脆弱性。
Expert Opin Ther Targets. 2021 Jan;25(1):27-36. doi: 10.1080/14728222.2021.1864321. Epub 2021 Jan 8.
2
Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis.基于结构的苯并恶唑啉衍生物的药物设计作为跨损伤合成中 Rev1 相互作用的抑制剂。
ChemMedChem. 2021 Apr 8;16(7):1126-1132. doi: 10.1002/cmdc.202000893. Epub 2021 Jan 28.
3
Translesion synthesis inhibitors as a new class of cancer chemotherapeutics.
抗体体细胞超突变过程中 DNA 损伤与修复的分子机制。
Sci China Life Sci. 2024 Nov;67(11):2344-2353. doi: 10.1007/s11427-024-2615-1. Epub 2024 Jul 23.
4
Adaptive use of error-prone DNA polymerases provides flexibility in genome replication during tumorigenesis.易错 DNA 聚合酶的适应性利用为肿瘤发生过程中的基因组复制提供了灵活性。
Cancer Sci. 2024 Jul;115(7):2125-2137. doi: 10.1111/cas.16188. Epub 2024 Apr 23.
5
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.REV7 通过控制 DNA 损伤反应参与胰腺癌铂类化疗的结局。
Cancer Sci. 2024 Feb;115(2):660-671. doi: 10.1111/cas.16044. Epub 2023 Dec 21.
6
Role of Translesion DNA Synthesis in the Metabolism of Replication-associated Nascent Strand Gaps.跨损伤 DNA 合成在复制相关新生链缺口代谢中的作用。
J Mol Biol. 2024 Jan 1;436(1):168275. doi: 10.1016/j.jmb.2023.168275. Epub 2023 Sep 13.
7
REV7 in Cancer Biology and Management.癌症生物学与治疗中的REV7
Cancers (Basel). 2023 Mar 11;15(6):1721. doi: 10.3390/cancers15061721.
8
Beyond the Lesion: Back to High Fidelity DNA Synthesis.超越损伤:回归高保真DNA合成。
Front Mol Biosci. 2022 Jan 5;8:811540. doi: 10.3389/fmolb.2021.811540. eCollection 2021.
跨损伤合成抑制剂作为一类新型的癌症化疗药物。
Expert Opin Investig Drugs. 2021 Jan;30(1):13-24. doi: 10.1080/13543784.2021.1850692. Epub 2020 Dec 3.
4
Translesion DNA Synthesis and Carcinogenesis.跨损伤 DNA 合成与致癌作用。
Biochemistry (Mosc). 2020 Apr;85(4):425-435. doi: 10.1134/S0006297920040033.
5
Genetic determinants of cellular addiction to DNA polymerase theta.DNA 聚合酶 θ 细胞成瘾的遗传决定因素。
Nat Commun. 2019 Sep 19;10(1):4286. doi: 10.1038/s41467-019-12234-1.
6
A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.小分子靶向诱变跨损伤合成可改善化疗。
Cell. 2019 Jun 27;178(1):152-159.e11. doi: 10.1016/j.cell.2019.05.028. Epub 2019 Jun 6.
7
Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1.结构方法鉴定靶向跨损伤合成聚合酶 Rev1 的先导支架。
J Chem Inf Model. 2018 Nov 26;58(11):2266-2277. doi: 10.1021/acs.jcim.8b00535. Epub 2018 Oct 19.
8
Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.Rev7 二聚化对于 Rev1/Polζ 跨损伤合成复合物的组装和功能至关重要。
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8191-E8200. doi: 10.1073/pnas.1801149115. Epub 2018 Aug 15.
9
Small molecule scaffolds that disrupt the Rev1-CT/RIR protein-protein interaction.小分子支架可破坏 Rev1-CT/RIR 蛋白-蛋白相互作用。
Bioorg Med Chem. 2018 Aug 7;26(14):4301-4309. doi: 10.1016/j.bmc.2018.07.029. Epub 2018 Jul 19.
10
Structures of REV1 UBM2 Domain Complex with Ubiquitin and with a Small-Molecule that Inhibits the REV1 UBM2-Ubiquitin Interaction.REV1 UBM2 结构域与泛素以及抑制 REV1 UBM2-泛素相互作用的小分子的复合物结构。
J Mol Biol. 2018 Aug 17;430(17):2857-2872. doi: 10.1016/j.jmb.2018.05.042. Epub 2018 Jun 2.